Novo Nordisk’s Amycretin Outperforms Wegovy in Initial Trial: Insights into the New Weight Loss Pill from the Maker of Ozempic
Mar 7, 2024,12:28pm EST Novo Nordisk, the manufacturer behind Ozempic, has hinted at a potential successor to its widely successful weight loss drug Wegovy. This revelation comes amidst a flurry of activity in the development of next-generation obesity treatments, with consumers increasingly drawn to powerful medications. Competitors like Eli Lilly, Pfizer, and a host of […]








